Patent: 10,004,686
✉ Email this page to a colleague
Summary for Patent: 10,004,686
Title: | Lipid construct for delivery of insulin to a mammal |
Abstract: | The instant invention is drawn to a hepatocyte targeted composition comprising insulin associated with a lipid construct comprising an amphipathic lipid and an extended amphipathic lipid that targets the construct to a receptor displayed by an hepatocyte. The composition can comprise a mixture of free insulin and insulin associated with the complex. The composition can be modified to protect insulin and the complex from degradation. The invention also includes methods for the manufacture of the composition and loading insulin into the composition and recycling various components of the composition. Methods of treating individuals inflicted with diabetes. |
Inventor(s): | Lau; John R. (Howard, OH), Geho; W. Blair (Wooster, OH) |
Assignee: | SDG, Inc. (Cleveland, OH) |
Application Number: | 13/916,115 |
Patent Claims: | see list of patent claims |
Details for Patent 10,004,686
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | October 28, 1982 | 10,004,686 | 2025-05-23 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | December 29, 2015 | 10,004,686 | 2025-05-23 |
Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | August 06, 1998 | 10,004,686 | 2025-05-23 |
Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | March 31, 1994 | 10,004,686 | 2025-05-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |